Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.43 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.07.
Market Cap
9.43T
Revenue
4.67T
Profits
188.42B
PE Ratio
50.07
Profit Margin
4.04%
Dividend Yield
0.39%
1051 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.12T | 0.43% | 2,385,226 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 615.87B | 0.90% | 6,397,404 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 504.37B | 0.71% | 5,643,863 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 360.32B | -1.29% | 8,106,960 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 360.08B | 0.52% | 11,103,830 | 66.57B |
| 6 | NVS | Novartis AG | 287.68B | 0.16% | 1,728,787 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 257.52B | -0.76% | 3,356,406 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 255.13B | -0.93% | 2,098,569 | 46.34B |
| 9 | AMGN | Amgen Inc. | 233.82B | -0.35% | 2,568,906 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 193.67B | -0.75% | 7,766,547 | 30.46B |
| 11 | ABT | Abbott Laboratories | 181.50B | 0.20% | 8,236,517 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 172.77B | -0.99% | 9,457,788 | 50.34B |
| 13 | PFE | Pfizer Inc. | 168.60B | 0.48% | 28,605,606 | 63.70B |
| 14 | DHR | Danaher Corporation | 161.01B | -1.06% | 3,518,492 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 150.74B | -0.27% | 2,576,806 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 126.66B | -1.77% | 1,409,295 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 122.05B | -1.35% | 12,831,028 | 49.19B |
| 18 | CVS | CVS Health Corporation | 118.13B | -0.24% | 6,984,924 | 412.65B |
| 19 | MCK | McKesson Corporation | 117.15B | 0.62% | 621,692 | 410.98B |
| 20 | MDT | Medtronic plc | 115.99B | -0.73% | 31,346,996 | 37.54B |
| 21 | SYK | Stryker Corporation | 113.02B | 0.49% | 3,378,308 | 25.84B |
| 22 | GSK | GSK plc | 99.56B | 1.00% | 6,917,280 | 44.05B |
| 23 | HCA | HCA Healthcare, Inc. | 99.34B | -2.06% | 1,716,584 | 78.01B |
| 24 | SNY | Sanofi | 96.96B | 0.79% | 4,631,822 | 55.89B |
| 25 | ELV | Elevance Health, Inc. | 92.88B | -0.04% | 1,206,720 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 87.04B | -7.82% | 21,386,437 | 2.23B |
| 27 | CI | The Cigna Group | 79.88B | 1.17% | 1,536,899 | 282.38B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 78.96B | -0.70% | 653,853 | 15.53B |
| 29 | COR | Cencora, Inc. | 65.06B | -0.14% | 1,979,528 | 332.77B |
| 30 | BSX | Boston Scientific Corporation | 64.33B | 0.57% | 12,413,460 | 21.00B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 62.94B | 1.13% | 2,718,107 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 58.83B | 0.14% | 1,337,196 | 254.25B |
| 33 | NTRA | Natera, Inc. | 56.71B | -2.80% | 1,581,348 | 2.71B |
| 34 | BDX | Becton, Dickinson and Company | 52.23B | -1.04% | 1,413,610 | 22.48B |
| 35 | ARGX | argenx SE | 51.19B | -3.21% | 388,973 | 5.32B |
| 36 | VEEV | Veeva Systems Inc. | 50.25B | -0.85% | 1,730,462 | 3.46B |
| 37 | EW | Edwards Lifesciences Corporation | 49.92B | -1.70% | 4,009,410 | 6.51B |
| 38 | HUM | Humana Inc. | 49.61B | -4.41% | 1,395,414 | 145.68B |
| 39 | A | Agilent Technologies, Inc. | 48.77B | -1.47% | 2,900,998 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 48.36B | 0.95% | 5,936,551 | 17.32B |
| 41 | MDLN | Medline Inc. | 47.28B | -1.67% | 7,078,990 | 29.94B |
| 42 | IDXX | IDEXX Laboratories, Inc. | 44.15B | 2.41% | 709,088 | 4.55B |
| 43 | HLN | Haleon plc | 44.08B | 1.91% | 17,995,338 | 14.80B |
| 44 | IQV | IQVIA Holdings Inc. | 43.93B | -1.53% | 1,037,603 | 16.98B |
| 45 | WAT | Waters Corporation | 42.93B | -1.62% | 902,298 | 4.64B |
| 46 | ONC | BeOne Medicines AG | 41.96B | -1.34% | 422,234 | 6.13B |
| 47 | ILMN | Illumina, Inc. | 39.64B | -2.01% | 2,489,441 | 4.49B |
| 48 | RVMD | Revolution Medicines, Inc. | 38.14B | -5.97% | 2,973,185 | - |
| 49 | RPRX | Royalty Pharma plc | 35.05B | 2.25% | 5,786,281 | 2.54B |
| 50 | BIIB | Biogen Inc. | 34.37B | -1.15% | 1,463,049 | 10.03B |
| 51 | CNC | Centene Corporation | 34.16B | -1.91% | 3,337,777 | 180.30B |
| 52 | RMD | ResMed Inc. | 33.61B | -1.35% | 2,522,951 | 5.65B |
| 53 | ZTS | Zoetis Inc. | 32.80B | 1.22% | 5,209,732 | 9.53B |
| 54 | MTD | Mettler-Toledo International Inc. | 32.51B | -1.02% | 263,948 | 4.13B |
| 55 | DXCM | DexCom, Inc. | 32.47B | -1.90% | 3,501,800 | 4.97B |
| 56 | ALC | Alcon Inc. | 32.12B | -0.60% | 1,453,931 | 10.86B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 31.42B | -1.11% | 3,116,206 | 21.27B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.02B | -0.94% | 1,404,750 | 4.80B |
| 59 | WST | West Pharmaceutical Services, Inc. | 27.03B | 0.26% | 511,421 | 3.33B |
| 60 | DGX | Quest Diagnostics Incorporated | 25.94B | -1.74% | 800,026 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 25.79B | -2.19% | 679,544 | 14.35B |
| 62 | PHG | Koninklijke Philips N.V. | 25.47B | 0.98% | 1,338,633 | 20.18B |
| 63 | ROIV | Roivant Sciences Ltd. | 24.22B | -1.50% | 4,923,420 | 7.53M |
| 64 | INCY | Incyte Corporation | 22.92B | -0.18% | 1,580,704 | 5.82B |
| 65 | UTHR | United Therapeutics Corporation | 22.87B | -1.55% | 654,280 | 3.15B |
| 66 | GMAB | Genmab A/S | 22.50B | -2.17% | 2,684,721 | 4.13B |
| 67 | BNTX | BioNTech SE | 22.03B | -2.76% | 1,104,150 | 3.03B |
| 68 | STE | STERIS plc | 21.71B | -0.74% | 601,760 | 6.04B |
| 69 | THC | Tenet Healthcare Corporation | 21.52B | -2.86% | 818,125 | 21.81B |
| 70 | VTRS | Viatris Inc. | 21.43B | 2.39% | 9,411,510 | 14.74B |
| 71 | GH | Guardant Health, Inc. | 21.28B | -4.39% | 1,975,411 | 1.18B |
| 72 | INSM | Insmed Incorporated | 21.02B | -2.96% | 2,395,740 | 1.14B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.12B | 0.64% | 1,935,935 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.26B | -1.61% | 297,570 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 17.03B | -1.34% | 1,336,608 | 2.91B |
| 76 | EXEL | Exelixis, Inc. | 15.42B | -0.95% | 2,637,178 | 2.44B |
| 77 | ASND | Ascendis Pharma A/S | 14.79B | -0.61% | 680,312 | 1.20B |
| 78 | SOLV | Solventum Corporation | 14.61B | -2.33% | 1,165,874 | 8.31B |
| 79 | CRL | Charles River Laboratories International, Inc. | 14.33B | -1.99% | 674,686 | 4.00B |
| 80 | HALO | Halozyme Therapeutics, Inc. | 13.83B | 0.27% | 2,081,608 | 1.66B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 13.79B | -0.86% | 1,076,612 | 3.37B |
| 82 | JAZZ | Jazz Pharmaceuticals plc | 13.65B | -1.95% | 636,698 | 4.60B |
| 83 | ICLR | ICON Public Limited Company | 13.13B | -2.83% | 667,914 | 8.29B |
| 84 | BAX | Baxter International Inc. | 13.07B | -1.86% | 4,408,157 | 11.47B |
| 85 | BBIO | BridgeBio Pharma, Inc. | 12.98B | -1.10% | 2,055,506 | 713.07M |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.68B | -2.39% | 1,693,912 | 14.37B |
| 87 | PEN | Penumbra, Inc. | 12.64B | -0.11% | 278,513 | 1.50B |
| 88 | EHC | Encompass Health Corporation | 12.61B | 0.08% | 1,289,659 | 6.21B |
| 89 | SNN | Smith & Nephew plc | 12.11B | -0.10% | 1,307,579 | 6.30B |
| 90 | DVA | DaVita Inc. | 11.95B | -0.98% | 505,368 | 14.01B |
| 91 | CORT | Corcept Therapeutics Incorporated | 11.91B | -2.83% | 849,626 | 830.81M |
| 92 | FMS | Fresenius Medical Care AG | 11.79B | 0.18% | 620,732 | 22.19B |
| 93 | ELAN | Elanco Animal Health Incorporated | 11.77B | 0.04% | 5,165,597 | 5.02B |
| 94 | SMMT | Summit Therapeutics Inc. | 11.70B | -4.81% | 4,313,704 | - |
| 95 | TEM | Tempus AI, Inc. | 11.68B | -9.01% | 6,850,968 | 1.43B |
| 96 | TECH | Bio-Techne Corporation | 11.38B | 0.07% | 2,646,860 | 1.22B |
| 97 | AVTR | Avantor, Inc. | 11.11B | 2.05% | 29,355,974 | 6.56B |
| 98 | COO | The Cooper Companies, Inc. | 11.02B | 0.94% | 3,773,925 | 4.24B |
| 99 | UHS | Universal Health Services, Inc. | 10.91B | -1.21% | 585,707 | 18.11B |
| 100 | RDY | Dr. Reddy's Laboratories Limited | 10.81B | 1.32% | 2,794,062 | 3.50B |
| 101 | MOH | Molina Healthcare, Inc. | 10.80B | -2.42% | 677,953 | 42.47B |
| 102 | BMRN | BioMarin Pharmaceutical Inc. | 10.58B | -2.44% | 2,624,657 | 3.41B |
| 103 | ALGN | Align Technology, Inc. | 10.46B | -1.36% | 953,187 | 4.14B |
| 104 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.39B | -2.19% | 364,504 | 1.28B |
| 105 | GMED | Globus Medical, Inc. | 10.30B | -2.70% | 1,940,426 | 3.14B |
| 106 | ENSG | The Ensign Group, Inc. | 10.21B | -0.83% | 286,813 | 5.49B |
| 107 | PCVX | Vaxcyte, Inc. | 10.01B | -2.53% | 3,374,505 | - |
| 108 | RGEN | Repligen Corporation | 9.90B | -4.75% | 1,223,759 | 785.10M |
| 109 | OSCR | Oscar Health, Inc. | 9.83B | -4.72% | 5,675,761 | 15.32B |
| 110 | PODD | Insulet Corporation | 9.79B | 1.68% | 1,618,397 | 3.05B |
| 111 | IBRX | ImmunityBio, Inc. | 9.73B | -8.20% | 21,439,645 | 165.79M |
| 112 | GKOS | Glaukos Corporation | 9.72B | -0.46% | 985,415 | 612.84M |
| 113 | HSIC | Henry Schein, Inc. | 9.63B | -0.70% | 1,179,130 | 13.60B |
| 114 | QGEN | Qiagen N.V. | 9.54B | -0.09% | 1,995,603 | 2.10B |
| 115 | BIO | Bio-Rad Laboratories, Inc. | 9.46B | -3.05% | 207,702 | 2.59B |
| 116 | KRYS | Krystal Biotech, Inc. | 9.37B | -4.07% | 226,220 | 440.48M |
| 117 | TXG | 10x Genomics, Inc. | 9.10B | -3.49% | 3,385,487 | 616.91M |
| 118 | KYMR | Kymera Therapeutics, Inc. | 8.71B | -3.11% | 488,723 | 105.00M |
| 119 | CAI | Caris Life Sciences, Inc. | 8.64B | -3.78% | 2,730,079 | 989.61M |
| 120 | CYTK | Cytokinetics, Incorporated | 8.61B | -3.08% | 1,204,435 | 67.67M |
| 121 | BRKR | Bruker Corporation | 8.35B | -3.11% | 1,674,167 | 3.50B |
| 122 | PTGX | Protagonist Therapeutics, Inc. | 8.33B | -5.71% | 886,732 | 281.99M |
| 123 | TWST | Twist Bioscience Corporation | 8.32B | -8.13% | 2,826,506 | 431.80M |
| 124 | AXSM | Axsome Therapeutics, Inc. | 8.23B | -2.87% | 873,076 | 776.57M |
| 125 | HNGE | Hinge Health, Inc. | 8.00B | -5.53% | 1,713,527 | 720.06M |
| 126 | ATR | AptarGroup, Inc. | 7.92B | 0.20% | 550,209 | 3.93B |
| 127 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.90B | -4.44% | 1,772,713 | 669.50M |
| 128 | ABVX | ABIVAX Société Anonyme | 7.74B | -4.60% | 1,297,267 | 5.33M |
| 129 | TGTX | TG Therapeutics, Inc. | 7.66B | -3.63% | 1,770,037 | 799.54M |
| 130 | HQY | HealthEquity, Inc. | 7.62B | -0.45% | 550,681 | 1.36B |
| 131 | SYRE | Spyre Therapeutics, Inc. | 7.47B | -0.25% | 1,273,321 | - |
| 132 | PACS | PACS Group, Inc. | 7.43B | -1.76% | 958,005 | 5.55B |
| 133 | IONS | Ionis Pharmaceuticals, Inc. | 7.14B | -2.67% | 1,674,763 | 874.09M |
| 134 | ALKS | Alkermes plc | 6.92B | 2.79% | 3,263,631 | 1.67B |
| 135 | GRFS | Grifols, S.A. | 6.82B | 1.33% | 872,358 | 8.48B |
| 136 | PRAX | Praxis Precision Medicines, Inc. | 6.75B | -2.61% | 502,560 | 7.46M |
| 137 | AMRX | Amneal Pharmaceuticals, Inc. | 6.68B | -0.36% | 2,286,719 | 3.12B |
| 138 | CHE | Chemed Corporation | 6.67B | -0.59% | 89,354 | 2.60B |
| 139 | HIMS | Hims & Hers Health, Inc. | 6.55B | -4.46% | 10,979,306 | 2.58B |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.51B | -0.29% | 1,711,509 | 1.56B |
| 141 | IOVA | Iovance Biotherapeutics, Inc. | 6.17B | -7.47% | 12,155,683 | 324.97M |
| 142 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.13B | -1.69% | 524,763 | 840.85M |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.93B | -2.05% | 364,054 | 239.92M |
| 144 | LGND | Ligand Pharmaceuticals Incorporated | 5.89B | -0.99% | 164,498 | 290.54M |
| 145 | BLCO | Bausch + Lomb Corporation | 5.89B | -1.02% | 419,845 | 5.32B |
| 146 | BLTE | Belite Bio, Inc | 5.76B | -6.31% | 177,231 | - |
| 147 | TFX | Teleflex Incorporated | 5.53B | 1.72% | 722,868 | 2.25B |
| 148 | IMVT | Immunovant, Inc. | 5.52B | -2.84% | 1,462,996 | - |
| 149 | DOCS | Doximity, Inc. | 5.52B | -1.68% | 3,582,647 | 655.57M |
| 150 | RDNT | RadNet, Inc. | 5.41B | -2.29% | 385,465 | 2.27B |
| 151 | HAE | Haemonetics Corporation | 5.38B | -2.48% | 467,009 | 1.35B |
| 152 | KOD | Kodiak Sciences Inc. | 5.38B | -2.69% | 1,122,131 | - |
| 153 | MMSI | Merit Medical Systems, Inc. | 5.33B | -0.41% | 484,425 | 1.58B |
| 154 | CGON | CG Oncology, Inc. | 5.31B | -3.23% | 1,079,665 | 6.23M |
| 155 | GRAL | GRAIL, Inc. | 5.26B | -13.03% | 1,304,708 | 165.26M |
| 156 | WAY | Waystar Holding Corp. | 5.25B | -3.12% | 2,707,235 | 1.21B |
| 157 | MIRM | Mirum Pharmaceuticals, Inc. | 5.21B | -2.68% | 462,923 | 618.07M |
| 158 | STVN | Stevanato Group S.p.A. | 5.16B | -1.82% | 277,778 | 1.40B |
| 159 | COGT | Cogent Biosciences, Inc. | 5.12B | 0.03% | 2,782,712 | - |
| 160 | SHC | Sotera Health Company | 5.11B | -1.00% | 1,855,399 | 1.22B |
| 161 | PTCT | PTC Therapeutics, Inc. | 4.94B | -2.87% | 787,545 | 1.01B |
| 162 | MMED | MiniMed Group, Inc. | 4.92B | -2.83% | 21,356,131 | 3.22B |
| 163 | CON | Concentra Group Holdings Parent, Inc. | 4.91B | -1.56% | 1,303,040 | 2.29B |
| 164 | SRRK | Scholar Rock Holding Corporation | 4.86B | -1.82% | 2,893,997 | - |
| 165 | ORKA | Oruka Therapeutics, Inc. | 4.76B | -2.63% | 1,388,174 | - |
| 166 | CRSP | CRISPR Therapeutics AG | 4.76B | -4.41% | 1,517,474 | 13.39M |
| 167 | RGC | Regencell Bioscience Holdings Limited | 4.76B | 0.74% | 680,273 | - |
| 168 | ERAS | Erasca, Inc. | 4.68B | -9.95% | 7,089,142 | - |
| 169 | TVTX | Travere Therapeutics, Inc. | 4.68B | -6.04% | 1,827,880 | 591.33M |
| 170 | OPCH | Option Care Health, Inc. | 4.67B | -0.06% | 2,817,857 | 5.69B |
| 171 | BLLN | BillionToOne, Inc. | 4.63B | -4.49% | 605,635 | 397.41M |
| 172 | MANE | Veradermics, Incorporated | 4.55B | -5.43% | 670,498 | - |
| 173 | LFST | LifeStance Health Group, Inc. | 4.49B | -5.09% | 2,824,769 | 1.58B |
| 174 | DFTX | Definium Therapeutics, Inc. | 4.31B | -6.30% | 1,933,980 | - |
| 175 | ITGR | Integer Holdings Corporation | 4.31B | -0.02% | 724,436 | 1.84B |
| 176 | LIVN | LivaNova PLC | 4.27B | -1.17% | 773,981 | 1.47B |
| 177 | HTFL | HeartFlow, Inc. | 4.20B | -5.15% | 1,001,668 | 212.07M |
| 178 | ICUI | ICU Medical, Inc. | 4.08B | -2.58% | 221,673 | 2.16B |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 4.04B | -2.64% | 1,143,648 | - |
| 180 | DNTH | Dianthus Therapeutics, Inc. | 4.03B | -3.27% | 1,053,338 | 1.90M |
| 181 | ADPT | Adaptive Biotechnologies Corporation | 3.83B | -6.10% | 1,940,957 | 308.08M |
| 182 | INDV | Indivior Pharmaceuticals, Inc. | 3.83B | -3.48% | 4,205,889 | 1.33B |
| 183 | ABCL | AbCellera Biologics Inc. | 3.82B | -6.94% | 4,098,331 | 66.17M |
| 184 | NHC | National HealthCare Corporation | 3.80B | -1.10% | 100,939 | 1.56B |
| 185 | TLX | Telix Pharmaceuticals Limited | 3.72B | 1.14% | 324,831 | 890.79M |
| 186 | TNGX | Tango Therapeutics, Inc. | 3.72B | -2.91% | 3,688,261 | 53.81M |
| 187 | NVST | Envista Holdings Corporation | 3.68B | -2.55% | 2,324,175 | 2.86B |
| 188 | ARQT | Arcutis Biotherapeutics, Inc. | 3.62B | -0.89% | 1,731,947 | 463.98M |
| 189 | OGN | Organon & Co. | 3.61B | - | 2,646,609 | 6.13B |
| 190 | IRTC | iRhythm Holdings, Inc. | 3.58B | -0.65% | 398,615 | 825.34M |
| 191 | LEGN | Legend Biotech Corporation | 3.58B | -6.67% | 2,961,555 | 1.27B |
| 192 | RLAY | Relay Therapeutics, Inc. | 3.57B | -5.90% | 2,366,610 | 10.35M |
| 193 | VCYT | Veracyte, Inc. | 3.47B | -2.86% | 2,063,233 | 561.90M |
| 194 | CDNA | CareDx, Inc. | 3.31B | -4.02% | 1,497,639 | 458.09M |
| 195 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.31B | -4.74% | 1,150,551 | -665.00K |
| 196 | ACAD | Acadia Pharmaceuticals Inc. | 3.29B | -2.99% | 1,672,142 | 1.14B |
| 197 | XENE | Xenon Pharmaceuticals Inc. | 3.24B | -2.45% | 1,070,669 | 7.50M |
| 198 | IDYA | IDEAYA Biosciences, Inc. | 3.17B | -2.95% | 655,113 | 234.13M |
| 199 | PLSE | Pulse Biosciences, Inc. | 3.17B | -2.54% | 327,403 | 1.19M |
| 200 | LQDA | Liquidia Corporation | 3.07B | -1.24% | 4,238,324 | 450.91M |
| 201 | TARS | Tarsus Pharmaceuticals, Inc. | 2.99B | -4.11% | 2,432,245 | 606.33M |
| 202 | VKTX | Viking Therapeutics, Inc. | 2.94B | -8.04% | 7,564,473 | - |
| 203 | WRBY | Warby Parker Inc. | 2.89B | -5.08% | 2,786,865 | 911.61M |
| 204 | PRVA | Privia Health Group, Inc. | 2.88B | -0.44% | 1,247,557 | 2.36B |
| 205 | ATRC | AtriCure, Inc. | 2.85B | -2.96% | 648,335 | 569.62M |
| 206 | RCUS | Arcus Biosciences, Inc. | 2.82B | -3.07% | 1,425,531 | 117.00M |
| 207 | DNLI | Denali Therapeutics Inc. | 2.81B | -3.98% | 2,303,218 | 3.60M |
| 208 | PBLS | Parabilis Medicines, Inc. | 2.81B | -9.65% | 1,115,052 | 148.00K |
| 209 | ACHC | Acadia Healthcare Company, Inc. | 2.79B | -3.41% | 1,441,214 | 3.37B |
| 210 | CELC | Celcuity Inc. | 2.77B | -6.17% | 4,338,271 | - |
| 211 | ELVN | Enliven Therapeutics, Inc. | 2.73B | -5.11% | 1,188,419 | - |
| 212 | AVAH | Aveanna Healthcare Holdings Inc. | 2.69B | -2.37% | 1,365,226 | 2.60B |
| 213 | NRIX | Nurix Therapeutics, Inc. | 2.67B | -2.12% | 3,692,151 | 701.94M |
| 214 | DYN | Dyne Therapeutics, Inc. | 2.66B | -6.80% | 2,860,368 | - |
| 215 | ZLAB | Zai Lab Limited | 2.60B | -1.49% | 843,206 | 449.61M |
| 216 | NEOG | Neogen Corporation | 2.58B | -3.63% | 2,458,666 | 884.00M |
| 217 | HCM | HUTCHMED (China) Limited | 2.52B | 1.54% | 22,408 | 549.12M |
| 218 | GRDN | Guardian Pharmacy Services, Inc. | 2.50B | -0.53% | 451,033 | 1.46B |
| 219 | TMDX | TransMedics Group, Inc. | 2.45B | -7.50% | 1,067,832 | 668.47M |
| 220 | BKD | Brookdale Senior Living Inc. | 2.41B | - | 3,934,218 | 2.93B |
| 221 | ADMA | ADMA Biologics, Inc. | 2.39B | -0.47% | 3,073,662 | 512.28M |
| 222 | MBX | MBX Biosciences, Inc. | 2.39B | -2.13% | 818,907 | - |
| 223 | CLOV | Clover Health Investments, Corp. | 2.38B | -4.27% | 3,696,864 | 2.48B |
| 224 | NAMS | NewAmsterdam Pharma Company N.V. | 2.37B | -3.83% | 1,937,147 | 7.12M |
| 225 | PBH | Prestige Consumer Healthcare Inc. | 2.36B | 1.46% | 580,629 | 1.10B |
| 226 | BHC | Bausch Health Companies Inc. | 2.36B | -0.16% | 2,164,349 | 10.85B |
| 227 | BEAM | Beam Therapeutics Inc. | 2.35B | -5.10% | 1,645,093 | 156.04M |
| 228 | PRGO | Perrigo Company plc | 2.31B | 0.91% | 2,439,562 | 4.14B |
| 229 | PGEN | Precigen, Inc. | 2.29B | -11.32% | 5,477,157 | 85.72M |
| 230 | UFPT | UFP Technologies, Inc. | 2.26B | -1.86% | 82,184 | 631.64M |
| 231 | HRMY | Harmony Biosciences Holdings, Inc. | 2.21B | -0.76% | 892,251 | 959.90M |
| 232 | SUPN | Supernus Pharmaceuticals, Inc. | 2.20B | -4.37% | 1,441,614 | 830.44M |
| 233 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | -1.20% | 736,075 | 311.51M |
| 234 | IRON | Disc Medicine, Inc. | 2.18B | 0.34% | 560,577 | - |
| 235 | MD | Pediatrix Medical Group, Inc. | 2.17B | -1.37% | 534,979 | 1.95B |
| 236 | CLDX | Celldex Therapeutics, Inc. | 2.16B | -4.84% | 997,946 | 158.00K |
| 237 | VRDN | Viridian Therapeutics, Inc. | 2.16B | -2.71% | 2,457,260 | 71.13M |
| 238 | NEO | NeoGenomics, Inc. | 2.14B | -3.48% | 2,308,887 | 766.30M |
| 239 | FTRE | Fortrea Holdings Inc. | 2.14B | -1.14% | 1,837,670 | 2.68B |
| 240 | ADUS | Addus HomeCare Corporation | 2.12B | -0.49% | 136,879 | 1.48B |
| 241 | RXRX | Recursion Pharmaceuticals, Inc. | 2.07B | -16.71% | 40,553,689 | 54.86M |
| 242 | PGNY | Progyny, Inc. | 2.06B | -2.18% | 919,546 | 1.31B |
| 243 | VCEL | Vericel Corporation | 2.05B | -2.17% | 737,126 | 306.30M |
| 244 | AXGN | Axogen, Inc. | 2.03B | -2.86% | 1,127,465 | 251.17M |
| 245 | SLS | SELLAS Life Sciences Group, Inc. | 2.02B | -11.99% | 15,760,582 | - |
| 246 | VERA | Vera Therapeutics, Inc. | 2.01B | -2.42% | 1,294,215 | - |
| 247 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.99B | -2.87% | 4,396,151 | 940.61M |
| 248 | INSP | Inspire Medical Systems, Inc. | 1.99B | -1.90% | 414,140 | 898.74M |
| 249 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | -0.28% | 247,128 | 6.13M |
| 250 | PHVS | Pharvaris N.V. | 1.95B | -6.41% | 1,307,613 | - |
| 251 | BFLY | Butterfly Network, Inc. | 1.93B | -7.64% | 4,565,727 | 112.14M |
| 252 | TRLV | Trulieve Cannabis Corp. | 1.93B | -2.82% | 913,848 | 1.14B |
| 253 | LKFT | Lakefront Biotherapeutics NV | 1.90B | 0.10% | 250,892 | 1.13B |
| 254 | WGS | GeneDx Holdings Corp. | 1.90B | -9.37% | 644,155 | 454.43M |
| 255 | SGRY | Surgery Partners, Inc. | 1.90B | -1.02% | 966,757 | 3.37B |
| 256 | ASTH | Astrana Health, Inc. | 1.88B | -3.21% | 239,989 | 3.84B |
| 257 | XERS | Xeris Biopharma Holdings, Inc. | 1.88B | 2.38% | 2,288,655 | 335.41M |
| 258 | IMNM | Immunome, Inc. | 1.87B | -5.34% | 1,296,636 | 4.02M |
| 259 | AGIO | Agios Pharmaceuticals, Inc. | 1.87B | -3.09% | 952,660 | 98.34M |
| 260 | NVAX | Novavax, Inc. | 1.86B | -12.17% | 9,870,623 | 413.80M |
| 261 | LMAT | LeMaitre Vascular, Inc. | 1.85B | -2.81% | 311,545 | 262.43M |
| 262 | SRPT | Sarepta Therapeutics, Inc. | 1.81B | -3.88% | 9,855,870 | 1.97B |
| 263 | MESO | Mesoblast Limited | 1.80B | -4.80% | 615,686 | 120.25M |
| 264 | MLYS | Mineralys Therapeutics, Inc. | 1.79B | -6.19% | 1,181,193 | - |
| 265 | ALVO | Alvotech | 1.78B | -5.84% | 1,058,953 | 494.61M |
| 266 | ZYME | Zymeworks Inc. | 1.78B | -2.80% | 631,860 | 37.13M |
| 267 | ESTA | Establishment Labs Holdings Inc. | 1.76B | -3.54% | 293,820 | 245.82M |
| 268 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.76B | -3.96% | 2,215,098 | 208.78M |
| 269 | ALMR | Alamar Biosciences, Inc. | 1.75B | -7.80% | 456,178 | 100.42M |
| 270 | PVLA | Palvella Therapeutics, Inc. | 1.73B | -5.53% | 179,489 | - |
| 271 | ALHC | Alignment Healthcare, Inc. | 1.72B | 1.60% | 5,416,319 | 4.58B |
| 272 | XRAY | DENTSPLY SIRONA Inc. | 1.71B | -2.94% | 4,176,053 | 3.64B |
| 273 | XNCR | Xencor, Inc. | 1.70B | -4.79% | 1,129,943 | 104.97M |
| 274 | SEPN | Septerna, Inc. | 1.70B | -2.94% | 234,122 | 98.88M |
| 275 | TRVI | Trevi Therapeutics, Inc. | 1.69B | -1.90% | 2,704,402 | - |
| 276 | SDGR | Schrödinger, Inc. | 1.69B | -11.30% | 2,719,188 | 259.04M |
| 277 | URGN | UroGen Pharma Ltd. | 1.69B | -5.60% | 1,046,260 | 188.73M |
| 278 | ARDT | Ardent Health, Inc. | 1.69B | -2.05% | 660,134 | 6.41B |
| 279 | VIR | Vir Biotechnology, Inc. | 1.69B | -4.87% | 1,735,243 | 303.23M |
| 280 | SNDA | Sonida Senior Living, Inc. | 1.67B | -1.62% | 399,726 | 481.07M |
| 281 | PSNL | Personalis, Inc. | 1.67B | -1.76% | 3,304,766 | 69.67M |
| 282 | NVCR | NovoCure Limited | 1.64B | -2.43% | 1,287,602 | 699.19M |
| 283 | BHVN | Biohaven Ltd. | 1.63B | -5.69% | 2,423,654 | - |
| 284 | KMTS | Kestra Medical Technologies, Ltd. | 1.62B | -5.02% | 521,896 | 106.73M |
| 285 | ZBIO | Zenas BioPharma, Inc. | 1.62B | -2.20% | 661,703 | 1.00M |
| 286 | ATEC | Alphatec Holdings, Inc. | 1.62B | -4.30% | 2,702,726 | 815.05M |
| 287 | OMCL | Omnicell, Inc. | 1.61B | -1.56% | 426,646 | 1.25B |
| 288 | NTLA | Intellia Therapeutics, Inc. | 1.60B | 0.71% | 8,219,716 | 59.51M |
| 289 | PAHC | Phibro Animal Health Corporation | 1.58B | 2.19% | 186,992 | 1.52B |
| 290 | AMN | AMN Healthcare Services, Inc. | 1.57B | 1.23% | 1,545,760 | 3.43B |
| 291 | NUVB | Nuvation Bio Inc. | 1.56B | -6.32% | 4,470,400 | 169.90M |
| 292 | STOK | Stoke Therapeutics, Inc. | 1.56B | -1.79% | 880,121 | 27.59M |
| 293 | GENB | Generate Biomedicines, Inc. | 1.55B | -7.43% | 1,074,650 | 26.48M |
| 294 | ANIP | ANI Pharmaceuticals, Inc. | 1.55B | - | 333,921 | 978.38M |
| 295 | MAZE | Maze Therapeutics, Inc. | 1.53B | 0.18% | 1,018,474 | 20.00M |
| 296 | IMCR | Immunocore Holdings plc | 1.51B | -0.27% | 924,921 | 430.78M |
| 297 | QURE | uniQure N.V. | 1.51B | -3.29% | 1,292,840 | 18.67M |
| 298 | BRVE | Braveheart Bio, Inc. | 1.51B | -5.42% | 414,852 | - |
| 299 | OCUL | Ocular Therapeutix, Inc. | 1.51B | -6.91% | 2,761,251 | 52.06M |
| 300 | GPCR | Structure Therapeutics Inc. | 1.50B | -5.00% | 1,160,591 | - |
| 301 | INVA | Innoviva, Inc. | 1.50B | -0.38% | 550,474 | 440.00M |
| 302 | AZTA | Azenta, Inc. | 1.49B | -6.65% | 1,262,392 | 613.81M |
| 303 | CMPS | COMPASS Pathways plc | 1.49B | -7.49% | 4,966,420 | - |
| 304 | KRSA | Korsana Biosciences, Inc. | 1.49B | -3.02% | 112,916 | - |
| 305 | PNTG | The Pennant Group, Inc. | 1.46B | -0.83% | 181,645 | 1.10B |
| 306 | KLRA | Kailera Therapeutics, Inc. | 1.46B | -3.93% | 1,299,332 | - |
| 307 | HCSG | Healthcare Services Group, Inc. | 1.45B | -1.40% | 633,806 | 1.86B |
| 308 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.03% | 960,886 | 746.16M |
| 309 | ETON | Eton Pharmaceuticals, Inc. | 1.44B | -1.99% | 463,229 | 105.60M |
| 310 | CERT | Certara, Inc. | 1.43B | -3.00% | 2,359,197 | 421.75M |
| 311 | AGL | agilon health, inc. | 1.43B | -3.76% | 123,160 | 5.92B |
| 312 | RARE | Ultragenyx Pharmaceutical Inc. | 1.43B | -4.15% | 2,924,015 | 717.00M |
| 313 | ABSI | Absci Corporation | 1.42B | -7.09% | 3,535,444 | 1.56M |
| 314 | COAG | Hemab Therapeutics Holdings, Inc. | 1.40B | -7.66% | 351,756 | - |
| 315 | CNMD | CONMED Corporation | 1.40B | -0.89% | 413,962 | 1.37B |
| 316 | AAPG | Ascentage Pharma Group International | 1.39B | 4.63% | 15,091 | 94.61M |
| 317 | ANAB | AnaptysBio, Inc. | 1.39B | -4.31% | 413,631 | 106.09M |
| 318 | RAPP | Rapport Therapeutics, Inc. | 1.32B | -6.76% | 412,062 | 20.00M |
| 319 | INBX | Inhibrx Biosciences, Inc. | 1.32B | -0.74% | 145,953 | 1.30M |
| 320 | ORIC | ORIC Pharmaceuticals, Inc. | 1.28B | -3.29% | 946,149 | - |
| 321 | USPH | U.S. Physical Therapy, Inc. | 1.28B | -0.31% | 245,986 | 804.27M |
| 322 | NUTX | Nutex Health Inc. | 1.27B | -7.32% | 121,013 | 846.72M |
| 323 | TYRA | Tyra Biosciences, Inc. | 1.27B | -2.73% | 648,944 | - |
| 324 | FRNM | Freenome, Inc. | 1.26B | -4.39% | 902,987 | 35.41M |
| 325 | GHRS | GH Research PLC | 1.25B | -3.46% | 162,602 | - |
| 326 | TRAX | First Tracks Biotherapeutics, Inc. | 1.23B | -4.38% | 1,041,417 | - |
| 327 | NKTR | Nektar Therapeutics | 1.22B | -5.14% | 784,232 | 54.59M |
| 328 | KARD | Kardigan, Inc. | 1.22B | -6.20% | 717,612 | - |
| 329 | INNV | InnovAge Holding Corp. | 1.21B | -1.34% | 381,987 | 989.71M |
| 330 | CRON | Cronos Group Inc. | 1.19B | 0.31% | 863,191 | 179.09M |
| 331 | LBRX | LB Pharmaceuticals Inc | 1.19B | 0.14% | 724,736 | - |
| 332 | TSHA | Taysha Gene Therapies, Inc. | 1.18B | -2.95% | 2,751,375 | 5.49M |
| 333 | OMER | Omeros Corporation | 1.17B | -13.78% | 3,962,367 | 38.42M |
| 334 | AHG | Akso Health Group | 1.16B | - | 3,611 | 13.83M |
| 335 | SNDX | Syndax Pharmaceuticals, Inc. | 1.15B | -5.49% | 2,837,588 | 252.25M |
| 336 | GDRX | GoodRx Holdings, Inc. | 1.15B | -4.14% | 847,261 | 785.23M |
| 337 | OPK | OPKO Health, Inc. | 1.14B | -4.97% | 11,966,101 | 587.90M |
| 338 | DMRA | Damora Therapeutics, Inc. | 1.14B | -1.60% | 836,705 | - |
| 339 | DRTS | Alpha Tau Medical Ltd. | 1.13B | -6.61% | 778,734 | - |
| 340 | SVRA | Savara Inc. | 1.13B | -6.12% | 2,232,230 | - |
| 341 | TNDM | Tandem Diabetes Care, Inc. | 1.13B | -1.69% | 1,634,310 | 1.04B |
| 342 | ENOV | Enovis Corporation | 1.13B | 1.24% | 1,340,961 | 2.30B |
| 343 | IRMD | IRADIMED CORPORATION | 1.13B | -1.14% | 78,799 | 86.34M |
| 344 | IAM | Iambic Therapeutics, Inc. | 1.13B | 25.91% | 2,941,220 | 18.25M |
| 345 | BVS | Bioventus Inc. | 1.12B | -3.58% | 332,925 | 581.85M |
| 346 | CTY | City Therapeutics, Inc. | 1.11B | 24.44% | 1,405,832 | 14.34M |
| 347 | BCAX | Bicara Therapeutics Inc. | 1.11B | -4.77% | 819,996 | - |
| 348 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.10B | -2.08% | 351,982 | 730.02M |
| 349 | NBTX | Nanobiotix S.A. | 1.09B | -4.18% | 77,771 | 13.15M |
| 350 | OMDA | Omada Health, Inc. | 1.08B | -5.57% | 804,184 | 309.76M |
| 351 | VOR | Vor Biopharma Inc. | 1.07B | -6.77% | 733,077 | - |
| 352 | STAA | STAAR Surgical Company | 1.07B | -4.45% | 635,671 | 339.59M |
| 353 | AORT | Artivion, Inc. | 1.06B | -0.41% | 433,646 | 471.47M |
| 354 | VSTM | Verastem, Inc. | 1.05B | -6.28% | 6,087,645 | 87.53M |
| 355 | AVLN | Avalyn Pharma Inc. | 1.05B | -3.98% | 291,431 | - |
| 356 | LMRI | Lumexa Imaging Holdings, Inc. | 1.04B | 0.19% | 318,502 | 1.04B |
| 357 | TDOC | Teladoc Health, Inc. | 1.03B | -5.03% | 2,931,031 | 2.49B |
| 358 | IART | Integra LifeSciences Holdings Corporation | 1.03B | -2.37% | 830,981 | 1.65B |
| 359 | REPL | Replimune Group, Inc. | 1.02B | -7.57% | 1,710,753 | - |
| 360 | HROW | Harrow, Inc. | 1.02B | -5.11% | 560,045 | 275.59M |
| 361 | HSTM | HealthStream, Inc. | 1.01B | -1.84% | 207,256 | 321.12M |
| 362 | JANX | Janux Therapeutics, Inc. | 1.01B | -4.68% | 765,883 | 24.00M |
| 363 | PRCT | PROCEPT BioRobotics Corporation | 1.01B | -3.20% | 1,199,130 | 337.34M |
| 364 | MNKD | MannKind Corporation | 977.48M | -4.70% | 2,604,463 | 393.63M |
| 365 | CSTL | Castle Biosciences, Inc. | 976.36M | -5.44% | 380,930 | 357.28M |
| 366 | CBLL | CeriBell, Inc. | 960.99M | -9.41% | 406,586 | 101.96M |
| 367 | SPTX | Seaport Therapeutics, Inc. | 954.45M | 1.31% | 184,538 | - |
| 368 | LTGO | Latigo Biotherapeutics, Inc. | 928.19M | -5.15% | 207,358 | - |
| 369 | IMTX | Immatics N.V. | 919.92M | -5.74% | 1,154,876 | 47.65M |
| 370 | MGTX | MeiraGTx Holdings plc | 891.28M | -6.17% | 666,426 | 397.50M |
| 371 | QDEL | QuidelOrtho Corporation | 885.31M | -7.19% | 1,788,230 | 2.67B |
| 372 | SIBN | SI-BONE, Inc. | 882.03M | -1.16% | 1,165,641 | 213.60M |
| 373 | SLBT | SL Science Holding Limited | 869.66M | -1.61% | 24,821 | 3.27M |
| 374 | BBNX | Beta Bionics, Inc. | 862.80M | -5.31% | 660,830 | 119.01M |
| 375 | ANRO | Alto Neuroscience, Inc. | 860.97M | -3.01% | 648,343 | - |
| 376 | RIGL | Rigel Pharmaceuticals, Inc. | 858.34M | -2.75% | 141,429 | 276.79M |
| 377 | JBIO | Jade Biosciences, Inc. | 856.66M | -2.11% | 980,976 | - |
| 378 | AKTS | Aktis Oncology, Inc. | 837.63M | -5.93% | 394,795 | 10.06M |
| 379 | ABUS | Arbutus Biopharma Corporation | 834.92M | -1.63% | 4,541,643 | 181.72M |
| 380 | GLUE | Monte Rosa Therapeutics, Inc. | 830.95M | -3.75% | 883,187 | 28.73M |
| 381 | CGEM | Cullinan Therapeutics, Inc. | 830.82M | -7.79% | 1,123,252 | - |
| 382 | ODTX | Odyssey Therapeutics, Inc. | 822.76M | -2.28% | 219,368 | 99.00K |
| 383 | AVBP | ArriVent BioPharma, Inc. | 821.47M | -0.77% | 1,334,017 | - |
| 384 | INMD | InMode Ltd. | 813.93M | -1.12% | 417,144 | 374.63M |
| 385 | MLTX | MoonLake Immunotherapeutics | 812.77M | -6.92% | 1,380,680 | - |
| 386 | KURA | Kura Oncology, Inc. | 807.76M | -6.39% | 1,781,297 | 77.23M |
| 387 | AHCO | AdaptHealth Corp. | 805.12M | -5.56% | 2,090,957 | 3.36B |
| 388 | SGP | SpyGlass Pharma, Inc. | 802.75M | -2.91% | 70,647 | - |
| 389 | CRVS | Corvus Pharmaceuticals, Inc. | 801.67M | -3.25% | 1,035,515 | - |
| 390 | ALMS | Alumis Inc. | 792.14M | -3.01% | 2,496,311 | 7.40M |
| 391 | GMRS | GMR Solutions Inc. | 777.22M | -3.75% | 533,409 | 5.88B |
| 392 | VREX | Varex Imaging Corporation | 775.94M | -0.32% | 340,501 | 865.00M |
| 393 | HELP | Helus Pharma Inc. | 770.78M | -4.52% | 1,310,214 | - |
| 394 | ARDX | Ardelyx, Inc. | 769.99M | -5.50% | 5,775,542 | 450.89M |
| 395 | COLL | Collegium Pharmaceutical, Inc. | 754.96M | 0.04% | 558,643 | 808.21M |
| 396 | GERN | Geron Corporation | 751.69M | -4.88% | 3,953,562 | 204.56M |
| 397 | APMD | Apnimed, Inc. | 739.36M | -2.68% | 235,053 | 115.12M |
| 398 | OBX | Obsidian Therapeutics, Inc. | 727.07M | -3.52% | 297,675 | - |
| 399 | IVA | Inventiva S.A. | 727.00M | -5.47% | 4,852,207 | 2.81M |
| 400 | ANL | Adlai Nortye Group Ltd. | 710.31M | -8.77% | 336,584 | 18.06M |
| 401 | DNA | Ginkgo Bioworks Holdings, Inc. | 691.58M | -12.67% | 3,549,830 | 132.42M |
| 402 | CTKB | Cytek Biosciences, Inc. | 682.41M | -2.96% | 1,045,418 | 206.71M |
| 403 | SANA | Sana Biotechnology, Inc. | 679.55M | -8.28% | 3,088,227 | - |
| 404 | PHR | Phreesia, Inc. | 679.06M | -0.91% | 655,002 | 507.79M |
| 405 | LXRX | Lexicon Pharmaceuticals, Inc. | 676.33M | -7.88% | 2,007,632 | 41.47M |
| 406 | FDMT | 4D Molecular Therapeutics, Inc. | 671.77M | -5.52% | 794,526 | 92.01M |
| 407 | OABI | OmniAb, Inc. | 667.34M | -2.96% | 969,406 | 38.46M |
| 408 | PHAR | Pharming Group N.V. | 667.25M | -2.80% | 9,028 | 366.48M |
| 409 | IMMX | Immix Biopharma, Inc. | 661.57M | -8.06% | 1,503,765 | - |
| 410 | ACHV | Achieve Life Sciences, Inc. | 656.52M | -8.46% | 1,990,372 | - |
| 411 | STLN | Starling Oncology, Inc. | 655.32M | -6.95% | 1,773,436 | 587.24M |
| 412 | ANNX | Annexon, Inc. | 648.36M | -5.00% | 5,100,780 | - |
| 413 | MDXG | MiMedx Group, Inc. | 645.72M | -5.34% | 2,728,255 | 355.17M |
| 414 | DSGN | Design Therapeutics, Inc. | 645.22M | -1.62% | 854,547 | - |
| 415 | GYRE | Gyre Therapeutics, Inc. | 644.69M | -5.00% | 142,874 | 109.82M |
| 416 | AURA | Aura Biosciences, Inc. | 632.60M | -3.79% | 762,443 | - |
| 417 | ATTO | Attovia Therapeutics, Inc. | 626.79M | -7.10% | 977,900 | 1.80M |
| 418 | CADL | Candel Therapeutics, Inc. | 626.69M | -8.08% | 1,512,451 | - |
| 419 | PRME | Prime Medicine, Inc. | 617.33M | -3.88% | 4,383,228 | 4.07M |
| 420 | WVE | Wave Life Sciences, Inc. | 616.76M | -1.88% | 3,281,706 | 65.37M |
| 421 | NVCT | Nuvectis Pharma, Inc. | 607.65M | -1.48% | 158,421 | - |
| 422 | AVTX | Avalo Therapeutics, Inc. | 604.41M | -6.16% | 971,072 | 59.00K |
| 423 | SLDB | Solid Biosciences Inc. | 592.96M | -3.66% | 1,401,827 | - |
| 424 | WEAV | Weave Communications, Inc. | 591.99M | 0.14% | 2,516,753 | 257.79M |
| 425 | ZVRA | Zevra Therapeutics, Inc. | 590.27M | -3.21% | 593,878 | 136.07M |
| 426 | AVR | Anteris Technologies Global Corp. | 589.84M | -4.87% | 1,032,893 | 2.24M |
| 427 | IRWD | Ironwood Pharmaceuticals, Inc. | 578.34M | -7.16% | 2,530,652 | 389.32M |
| 428 | OLMA | Olema Pharmaceuticals, Inc. | 575.73M | -4.22% | 1,081,293 | - |
| 429 | KIDS | OrthoPediatrics Corp. | 573.11M | -2.75% | 149,673 | 252.72M |
| 430 | SOPH | SOPHiA GENETICS SA | 572.91M | -7.68% | 915,440 | 86.17M |
| 431 | SGMT | Sagimet Biosciences Inc. | 568.69M | -1.84% | 1,088,857 | - |
| 432 | CRMD | CorMedix Inc. | 565.88M | -2.68% | 1,140,448 | 462.25M |
| 433 | CLYM | Climb Bio, Inc. | 564.02M | -9.99% | 990,343 | - |
| 434 | PHAT | Phathom Pharmaceuticals, Inc. | 549.66M | -7.73% | 1,254,048 | 239.66M |
| 435 | ETRA | Electra Therapeutics, Inc. | 549.21M | - | 1,380,472 | - |
| 436 | FLGT | Fulgent Genetics, Inc. | 546.45M | -6.94% | 443,163 | 323.93M |
| 437 | STTK | Shattuck Labs, Inc. | 543.97M | -1.99% | 648,464 | 1.00M |
| 438 | PACB | Pacific Biosciences of California, Inc. | 537.74M | -11.73% | 10,412,943 | 159.27M |
| 439 | VALN | Valneva SE | 537.43M | -5.08% | 9,483 | 163.30M |
| 440 | SLN | Silence Therapeutics plc | 522.02M | -7.27% | 1,131,128 | 615.00K |
| 441 | DBVT | DBV Technologies S.A. | 521.99M | -0.66% | 592,916 | 5.04M |
| 442 | EVO | Evotec SE | 516.83M | -2.11% | 82,402 | 819.47M |
| 443 | EVH | Evolent Health, Inc. | 516.68M | -6.16% | 2,077,921 | 2.10B |
| 444 | DRUG | Bright Minds Biosciences Inc. | 512.25M | -4.81% | 50,706 | - |
| 445 | TCMD | Tactile Systems Technology, Inc. | 510.13M | -3.31% | 214,528 | 350.31M |
| 446 | SSII | SS Innovations International, Inc. | 509.98M | -1.36% | 39,212 | 52.40M |
| 447 | PBYI | Puma Biotechnology, Inc. | 506.91M | -6.65% | 406,589 | 231.24M |
| 448 | CBIO | Crescent Biopharma, Inc. | 506.76M | -5.13% | 208,141 | 11.88M |
| 449 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 450 | CTMX | CytomX Therapeutics, Inc. | 496.81M | -5.39% | 3,178,634 | 18.30M |
| 451 | DCTH | Delcath Systems, Inc. | 488.56M | -4.93% | 383,853 | 95.42M |
| 452 | FTH | Faeth Therapeutics, Inc. | 485.80M | -8.74% | 595,929 | - |
| 453 | ACRS | Aclaris Therapeutics, Inc. | 482.81M | -6.02% | 2,455,553 | 8.22M |
| 454 | BWAY | BrainsWay Ltd. | 475.14M | -3.21% | 66,245 | 60.70M |
| 455 | AQST | Aquestive Therapeutics, Inc. | 474.43M | -6.90% | 5,244,083 | 54.09M |
| 456 | ANGO | AngioDynamics, Inc. | 472.69M | -2.94% | 890,685 | 325.38M |
| 457 | EOLS | Evolus, Inc. | 468.96M | -6.21% | 761,440 | 316.49M |
| 458 | ENTX | Entera Bio Ltd. | 466.11M | -3.25% | 572,831 | 42.00K |
| 459 | MASS | 908 Devices Inc. | 465.42M | -5.30% | 469,209 | 60.84M |
| 460 | NGNE | Neurogene Inc. | 465.26M | -2.92% | 571,499 | 925.00K |
| 461 | MNPR | Monopar Therapeutics Inc. | 464.95M | -3.52% | 142,398 | - |
| 462 | RGNX | REGENXBIO Inc. | 457.14M | -3.28% | 1,209,626 | 174.48M |
| 463 | SGHT | Sight Sciences, Inc. | 456.13M | -5.91% | 289,279 | 83.38M |
| 464 | ARVN | Arvinas, Inc. | 455.74M | -2.65% | 759,130 | 316.70M |
| 465 | KMDA | Kamada Ltd. | 454.57M | -0.89% | 41,628 | 191.85M |
| 466 | ALLO | Allogene Therapeutics, Inc. | 452.59M | -2.24% | 4,918,561 | 4.64M |
| 467 | OCS | Oculis Holding AG | 450.03M | -1.49% | 293,677 | 1.45M |
| 468 | TLRY | Tilray Brands, Inc. | 445.85M | -5.30% | 3,020,046 | 963.10M |
| 469 | NRC | NRC Health | 445.71M | -4.55% | 70,870 | 140.00M |
| 470 | BLSM | BlossomHill Therapeutics, Inc. | 443.08M | -6.94% | 293,107 | - |
| 471 | CERS | Cerus Corporation | 439.32M | -3.54% | 2,406,222 | 221.55M |
| 472 | EPRX | Eupraxia Pharmaceuticals Inc. | 435.64M | -2.22% | 582,306 | - |
| 473 | PRTA | Prothena Corporation plc | 428.66M | -1.68% | 670,248 | 54.53M |
| 474 | ALT | Altimmune, Inc. | 427.94M | -6.78% | 4,233,320 | 31.00K |
| 475 | MPLT | MapLight Therapeutics, Inc. | 427.93M | -3.99% | 359,057 | - |
| 476 | AUTL | Autolus Therapeutics plc | 425.86M | -6.98% | 2,349,774 | 117.39M |
| 477 | NPCE | NeuroPace, Inc. | 420.13M | -4.23% | 156,254 | 106.99M |
| 478 | OVID | Ovid Therapeutics Inc. | 419.89M | -4.87% | 1,325,038 | 1.58M |
| 479 | YDES | YD Bio Limited | 419.32M | -12.17% | 153,370 | 1.24M |
| 480 | SENS | Senseonics Holdings, Inc. | 410.83M | -5.59% | 608,476 | 48.55M |
| 481 | ASMB | Assembly Biosciences, Inc. | 409.04M | -2.33% | 167,734 | 74.85M |
| 482 | DMAC | DiaMedica Therapeutics Inc. | 408.22M | -5.85% | 260,777 | - |
| 483 | AGMB | AgomAb Therapeutics NV | 407.77M | -0.60% | 78,132 | - |
| 484 | TECX | Tectonic Therapeutic, Inc. | 403.69M | -3.05% | 175,415 | - |
| 485 | RCEL | AVITA Medical, Inc. | 403.29M | -2.76% | 318,348 | 75.63M |
| 486 | PROK | ProKidney Corp. | 402.09M | -8.59% | 1,654,055 | 818.00K |
| 487 | EIKN | Eikon Therapeutics, Inc. | 401.90M | -1.59% | 482,732 | - |
| 488 | SRTA | Strata Critical Medical, Inc. | 400.75M | 4.38% | 1,581,075 | 255.98M |
| 489 | SPRY | ARS Pharmaceuticals, Inc. | 399.78M | -1.23% | 2,331,995 | 116.93M |
| 490 | AUNA | Auna S.A. | 393.75M | 0.38% | 281,168 | 1.37B |
| 491 | CYH | Community Health Systems, Inc. | 390.32M | -3.68% | 957,302 | 11.98B |
| 492 | CAPR | Capricor Therapeutics, Inc. | 390.11M | -7.70% | 1,920,126 | 11.13M |
| 493 | OFIX | Orthofix Medical Inc. | 382.89M | -1.98% | 286,064 | 833.19M |
| 494 | MYGN | Myriad Genetics, Inc. | 380.69M | -8.51% | 1,421,912 | 806.60M |
| 495 | SCTX | Scribe Therapeutics Inc. | 380.15M | -3.09% | 201,393 | 33.30M |
| 496 | TKNO | Alpha Teknova, Inc. | 380.11M | -6.84% | 423,579 | 43.70M |
| 497 | TRXB | TRex Bio, Inc. | 377.18M | -1.06% | 81,864 | - |
| 498 | SI | Shoulder Innovations, Inc. | 376.61M | -1.52% | 61,624 | 60.06M |
| 499 | RZLT | Rezolute, Inc. | 375.53M | -8.21% | 1,397,813 | - |
| 500 | CTEV | Claritev Corporation | 374.88M | -7.29% | 190,575 | 994.67M |